ClinicalTrials.Veeva

Menu

Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Unknown

Conditions

Renal Cell Carcinoma

Treatments

Procedure: zero ischemia robot-assisted laparoscopic RFA assisted TE
Procedure: zero ischemia robot-assisted laparoscopic partial nephrectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT02924597
RenJiH-20160829

Details and patient eligibility

About

To evaluate the feasibility and efficiency of zero ischemia robot-assisted laparoscopic radio frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with robot-assisted laparoscopic partial nephrectomy without hilar clamping.

Enrollment

100 estimated patients

Sex

All

Ages

15 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with sporadic, unilateral, newly diagnosed T1a presumed renal cell carcinoma
  • patients scheduled for robot-assisted laparoscopic nephron sparing surgery
  • patients with normal contralateral renal function (differential renal function of >40% as determined by radionuclide scintigraphy)
  • patients agreeable to participate in this long-term follow-up study

Exclusion criteria

  • patients' aged >80 years
  • patients with other renal diseases,(including kidney stone, glomerular nephritis, etc.) which might affect the renal function of the operative kidney
  • patients not able to tolerate the robot-assisted laparoscopic procedure
  • patients with previous renal surgery or history of any inflammatory conditions of the operative kidney
  • patients with the renal tumor involving urinary collecting system

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Robot-assisted laparoscopic RFA assisted TE
Experimental group
Description:
RFA will be performed for 1 to 4 cycles for 4 to 12 minutes each depending on tumor size and depth. The tumor then will be laparoscopic enucleation without hilar clamping.
Treatment:
Procedure: zero ischemia robot-assisted laparoscopic RFA assisted TE
Robot-Assisted laparoscopic partial nephrectomy
Active Comparator group
Description:
The tumor then will be laparoscopic enucleation without hilar clamping.
Treatment:
Procedure: zero ischemia robot-assisted laparoscopic partial nephrectomy

Trial contacts and locations

1

Loading...

Central trial contact

Yiran Huang, MD.; Jin Zhang, PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems